The FDA's lax oversight of research in developing countries can do harm to vulnerable participants
- Written by C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut
Nearly 80% of participants in FDA-reviewed research trials live in foreign countries.Bet_Noire/iStock via Getty ImagesThe Research Brief is a short take about interesting academic work.
The Big Idea
The Food and Drug Administration provides less stringent oversight of overseas research trials used in deciding whether to approve a drug than those...
